Abstract:A novel protein scaffold based on the cystine knot domain of the agouti-related protein (AgRP) has been used to engineer mutants that can bind to the α v β 3 integrin receptor with high affinity and specificity. In the current study, an 18 F-labeled AgRP mutant (7C) was prepared and evaluated as a positron emission tomography (PET) probe for imaging tumor angiogenesis. AgRP-7C was synthesized by solid phase peptide synthesis and site-specifically conjugated with 4-nitrophenyl 2- 18/19 F-fluoropropionate ( 18/19 F-NFP) to produce the fluorinated peptide, 18/19 F-FP-AgRP-7C. Competition binding assays were used to measure the relative affinities of AgRP-7C and 19 F-FP-AgRP-7C to human glioblastoma U87MG cells that overexpress α v β 3 integrin. In addition, biodistribution, metabolic stability, and small animal PET imaging studies were conducted with 18 F-FP-AgRP-7C using U87MG tumor-bearing mice. Both AgRP-7C and 19 F-FP-AgRP-7C specifically competed with 125 I-echistatin for binding to U87MG cells with half maximal inhibitory concentration (IC 50 ) values of 9.40 and 8.37 nM, respectively. Non-invasive small animal PET imaging revealed that 18 F-FP-AgRP-7C exhibited rapid and good tumor uptake (3.24 percentage injected dose per gram [% ID/g] at 0.5 h post injection [p.i.]). The probe was rapidly cleared from the blood and from most organs, resulting in excellent tumor-to-normal tissue contrasts. Tumor uptake and rapid clearance were further confirmed with biodistribution studies. Furthermore, co-injection of 18 F-FP-AgRP-7C with a large molar excess of blocking peptide c(RGDyK) significantly inhibited tumor uptake in U87MG xenograft models, demonstrating the integrin-targeting specificity of the probe. Metabolite assays showed that the probe had high stability, making it suitable for in vivo applications. 18 F-FP-AgRP-7C exhibits promising in vivo properties such as rapid tumor targeting, good tumor uptake, and excellent tumor-to-normal tissue ratios, and warrants further investigation as a novel PET probe for imaging tumor angiogenesis.

SPIO-RGD Nanoparticles As a Molecular Targeting Probe for Imaging Tumor Angiogenesis Using Synchrotron Radiation.

Molecular Imaging of Tumor Angiogenesis Using Rgd-Labeled Iron Oxide Nanoparticles

Crgd-Functionalized, DOX-conjugated, and 64Cu-Labeled Superparamagnetic Iron Oxide Nanoparticles for Targeted Anticancer Drug Delivery and PET/MR Imaging

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging

Micro-CT molecular imaging of tumor angiogenesis using a magnetite nano-cluster probe.

99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast ( T 1 / T 2 ) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis

Tumor Angiogenesis Targeted Radiosensitization Therapy using Gold Nanoprobes Guided by MRI/SPECT Imaging.

Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.

Modification of MR Molecular Imaging Probes with Cysteine-Terminated Peptides and Their Potential for in Vivo Tumour Detection.

18F-Labeled Magnetic Nanoparticles for Monitoring Anti-Angiogenic Therapeutic Effects in Breast Cancer Xenografts.

A Novel Strategy for Surface Modification of Superparamagnetic Iron Oxide Nanoparticles for Lung Cancer Imaging

Novel Dual-Function Near-Infrared II Fluorescence and PET Probe for Tumor Delineation and Image-Guided Surgery.

Superparamagnetic Iron Oxide Nanoparticles for MR Imaging of Pancreatic Cancer: Potential for Early Diagnosis Through Targeted Strategies

Improving Sensitivity of Magnetic Resonance Imaging by Using a Dual-Targeted Magnetic Iron Oxide Nanoprobe.

Noninvasive Monitoring of Early Antiangiogenic Therapy Response in Human Nasopharyngeal Carcinoma Xenograft Model Using MRI with RGD-conjugated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles

Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging

Engineered Superparamagnetic Iron Oxide Nanoparticles (spions) for Dual-Modality Imaging of Intracranial Glioblastoma Via EGFRvIII Targeting

Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles.

Multifunctional Ph-Sensitive Superparamagnetic Iron-Oxide Nanocomposites for Targeted Drug Delivery and Mr Imaging

High Resolution X-Ray Microangiography of 4T1 Tumor in Mouse Using Synchrotron Radiation